{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:06:53Z","timestamp":1789024013104,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1020280"],"award-info":[{"award-number":["1020280"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1118170"],"award-info":[{"award-number":["APP1118170"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["IIRS-18-147"],"award-info":[{"award-number":["IIRS-18-147"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000950","name":"CCA | Cancer Council South Australia","doi-asserted-by":"publisher","award":["PRF2518"],"award-info":[{"award-number":["PRF2518"]}],"id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Triple-negative breast cancer (TNBC) has a high incidence of metastasis and limited therapeutic options. Here, we identify a multimodal and targetable miR-342-E2F network that regulates metastatic outgrowth in TNBC. Through integrating clinical and experimental datasets, we uncover miR-342 as a suppressor of TNBC metastasis. Temporal re-expression of miR-342 significantly inhibited metastatic progression in both immunocompetent and xenograft TNBC models by specifically limiting the outgrowth of disseminated tumour cells. Using multi-omics profiling, we identified the global complement of miR-342 targets, demonstrating that it directly suppresses transcriptional and post-transcriptional networks that converge to dampen E2F signalling. Single-cell analysis of matched primary and metastatic patient-derived TNBC samples reveals activation of E2F signalling in metastasis that corresponds with reduced miR-342 host gene\n                    <jats:italic>EVL<\/jats:italic>\n                    expression. Furthermore, pharmacologic inhibition of this pathway with the CDK4\/6 inhibitor palbociclib specifically reduces metastatic outgrowth of pre-established TNBC lesions. Our findings reveal that TNBCs with low miR-342\/high E2F signalling have increased metastatic competency and may be amenable to CDK4\/6 inhibitor therapy, offering a potential strategy for targeted intervention to limit TNBC metastasis.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00496-4","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:01:40Z","timestamp":1787302900000},"page":"3619-3648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F network"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6642-0079","authenticated-orcid":false,"given":"Victoria K","family":"Arnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron N","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4527-7938","authenticated-orcid":false,"given":"Richard P","family":"Redvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-9768","authenticated-orcid":false,"given":"Caroline A","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-889X","authenticated-orcid":false,"given":"Katherine A","family":"Pillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5135-6504","authenticated-orcid":false,"given":"John","family":"Toubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Lumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6103-5165","authenticated-orcid":false,"given":"B Kate","family":"Dredge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3876-1537","authenticated-orcid":false,"given":"Andrew G","family":"Bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hackett-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pannapa","family":"Pinweha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe K","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-0378","authenticated-orcid":false,"given":"Kaitlin G","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasleen","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0203-1682","authenticated-orcid":false,"given":"Ashleigh B","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraya","family":"Roslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-9502","authenticated-orcid":false,"given":"Traude H","family":"Beilharz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron P","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0473-5392","authenticated-orcid":false,"given":"Yeesim","family":"Khew-Goodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-0692","authenticated-orcid":false,"given":"Gregory J","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6841-7422","authenticated-orcid":false,"given":"Robin L","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-0632","authenticated-orcid":false,"given":"Philip A","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"496_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/onc.2013.540","volume":"34","author":"ER Andrechek","year":"2015","unstructured":"Andrechek ER (2015) HER2\/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors. Oncogene 34:217\u2013225","journal-title":"Oncogene"},{"key":"496_CR2","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1158\/1078-0432.CCR-17-0369","volume":"23","author":"US Asghar","year":"2017","unstructured":"Asghar US, Barr AR, Cutts R, Beaney M, Babina I, Sampath D, Giltnane J, Lacap JA, Crocker L, Young A et al (2017) Single-cell dynamics determines response to CDK4\/6 inhibition in triple-negative breast cancer. Clin Cancer Res 23:5561\u20135572","journal-title":"Clin Cancer Res"},{"key":"496_CR3","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52:1399\u20131405","journal-title":"Cancer Res"},{"key":"496_CR4","first-page":"361","volume":"3","author":"M Bastian","year":"2009","unstructured":"Bastian M, Heymann S, Jacomy M (2009) Gephi: an open source software for exploring and manipulating networks. Int AAAI Conf Weblogs Soc Media 3:361\u2013362","journal-title":"Int AAAI Conf Weblogs Soc Media"},{"key":"496_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674\u2013690","journal-title":"Nat Rev Clin Oncol"},{"key":"496_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L (2022) Treatment landscape of triple-negative breast cancer-expanded options, evolving needs. Nat Rev Clin Oncol 19:91\u2013113","journal-title":"Nat Rev Clin Oncol"},{"key":"496_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrg.2016.134","volume":"17","author":"CP Bracken","year":"2016","unstructured":"Bracken CP, Scott HS, Goodall GJ (2016) A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet 17:719\u2013732","journal-title":"Nat Rev Genet"},{"key":"496_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115592","volume":"44","author":"C Bresesti","year":"2025","unstructured":"Bresesti C, Carito E, Notaro M, Giacca G, Breggion S, Kerzel T, Mercado CM, Beretta S, Monti M, Merelli I et al (2025) Reprogramming liver metastasis-associated macrophages toward an anti-tumoral phenotype through enforced miR-342 expression. Cell Rep 44:115592","journal-title":"Cell Rep"},{"key":"496_CR9","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1158\/0008-5472.CAN-11-0489","volume":"71","author":"FM Buffa","year":"2011","unstructured":"Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J (2011) microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 71:5635\u20135645","journal-title":"Cancer Res"},{"key":"496_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61\u201370.","journal-title":"Nature"},{"key":"496_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf1147","volume":"15","author":"A Chang","year":"2023","unstructured":"Chang A, Botteri E, Gillis RD, Lofling L, Le CP, Ziegler AI, Chung NC, Rowe MC, Fabb SA, Hartley BJ et al (2023) Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer. Sci Transl Med 15:eadf1147","journal-title":"Sci Transl Med"},{"key":"496_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10549-007-9761-y","volume":"111","author":"XZ Chang","year":"2008","unstructured":"Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM (2008) Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res Treat 111:65\u201378","journal-title":"Breast Cancer Res Treat"},{"key":"496_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/ijo.2020.5057","volume":"57","author":"F Chen","year":"2020","unstructured":"Chen F, Zhang Z, Yu Y, Liu Q, Pu F (2020) HSulf\u20111 and palbociclib exert synergistic antitumor effects on RB\u2011positive triple\u2011negative breast cancer. Int J Oncol 57:223\u2013236","journal-title":"Int J Oncol"},{"key":"496_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00413-7","volume":"11","author":"LH Chi","year":"2022","unstructured":"Chi LH, Cross RSN, Redvers RP, Davis M, Hediyeh-Zadeh S, Mathivanan S, Samuel M, Lucas EC, Mouchemore K, Gregory PA et al (2022) MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms. Oncogenesis 11:38","journal-title":"Oncogenesis"},{"key":"496_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01559-0","volume":"22","author":"LH Chi","year":"2024","unstructured":"Chi LH, Redfern AD, Roslan S, Street IP, Burrows AD, Anderson RL (2024) Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling. Cell Commun Signal 22:248","journal-title":"Cell Commun Signal"},{"key":"496_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature08170","volume":"460","author":"SW Chi","year":"2009","unstructured":"Chi SW, Zang JB, Mele A, Darnell RB (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460:479\u2013486","journal-title":"Nature"},{"key":"496_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1158\/1535-7163.MCT-20-0807","volume":"20","author":"JL Christenson","year":"2021","unstructured":"Christenson JL, O\u2019Neill KI, Williams MM, Spoelstra NS, Jones KL, Trahan GD, Reese J, Van Patten ET, Elias A, Eisner JR et al (2021) Activity of combined androgen receptor antagonism and cell cycle inhibition in androgen receptor positive triple negative breast cancer. Mol Cancer Ther 20:1062\u20131071","journal-title":"Mol Cancer Ther"},{"key":"496_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-317","volume":"9","author":"DM Cittelly","year":"2010","unstructured":"Cittelly DM, Das PM, Spoelstra NS, Edgerton SM, Richer JK, Thor AD, Jones FE (2010) Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer 9:317","journal-title":"Mol Cancer"},{"key":"496_CR19","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367\u20131372","journal-title":"Nat Biotechnol"},{"key":"496_CR20","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10:1794\u20131805","journal-title":"J Proteome Res"},{"key":"496_CR21","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1158\/1535-7163.MCT-21-0348","volume":"20","author":"A Cruz-Collazo","year":"2021","unstructured":"Cruz-Collazo A, Ruiz-Calderon JF, Picon H, Borrero-Garcia LD, Lopez I, Castillo-Pichardo L, Del Mar Maldonado M, Duconge J, Medina JI, Bayro MJ et al (2021) Efficacy of Rac and Cdc42 inhibitor MBQ-167 in triple-negative breast cancer. Mol Cancer Ther 20:2420\u20132432","journal-title":"Mol Cancer Ther"},{"key":"496_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486:346\u2013352","journal-title":"Nature"},{"key":"496_CR23","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/jca.18457","volume":"8","author":"X Dai","year":"2017","unstructured":"Dai X, Cheng H, Bai Z, Li J (2017) Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer 8:3131\u20133141","journal-title":"J Cancer"},{"key":"496_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/ng1651","volume":"37","author":"RA Dickins","year":"2005","unstructured":"Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW (2005) Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 37:1289\u20131295","journal-title":"Nat Genet"},{"key":"496_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fonc.2017.00101","volume":"7","author":"J Dooley","year":"2017","unstructured":"Dooley J, Lagou V, Pasciuto E, Linterman MA, Prosser HM, Himmelreich U, Liston A (2017) No functional role for microRNA-342 in a mouse model of pancreatic acinar carcinoma. Front Oncol 7:101","journal-title":"Front Oncol"},{"key":"496_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature12108","volume":"497","author":"H Dvinge","year":"2013","unstructured":"Dvinge H, Git A, Graf S, Salmon-Divon M, Curtis C, Sottoriva A, Zhao Y, Hirst M, Armisen J, Miska EA et al (2013) The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497:378\u2013382","journal-title":"Nature"},{"key":"496_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"MS Ebert","year":"2012","unstructured":"Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149:515\u2013524","journal-title":"Cell"},{"key":"496_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1541-7786.1.3.1","volume":"3","author":"BL Eckhardt","year":"2005","unstructured":"Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, Stanley KL, Sloan EK, Moseley JM, Anderson RL (2005) Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res 3:1\u201313","journal-title":"Mol Cancer Res"},{"key":"496_CR29","doi-asserted-by":"publisher","first-page":"e16915","DOI":"10.1371\/journal.pone.0016915","volume":"6","author":"E Enerly","year":"2011","unstructured":"Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Ronneberg JA, Johnsen H, Navon R, Rodland E et al (2011) miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 6:e16915","journal-title":"PLoS One"},{"key":"496_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb2210","volume":"6","author":"A Fassl","year":"2020","unstructured":"Fassl A, Brain C, Abu-Remaileh M, Stukan I, Butter D, Stepien P, Feit AS, Bergholz J, Michowski W, Otto T et al (2020) Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4\/6 inhibition. Sci Adv 6:eabb2210","journal-title":"Sci Adv"},{"key":"496_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108585","volume":"34","author":"RC Fernandes","year":"2021","unstructured":"Fernandes RC, Toubia J, Townley S, Hanson AR, Dredge BK, Pillman KA, Bert AG, Winter JM, Iggo R, Das R et al (2021) Post-transcriptional gene regulation by microRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer. Cell Rep 34:108585","journal-title":"Cell Rep"},{"key":"496_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2435-4","volume":"19","author":"M Foroutan","year":"2018","unstructured":"Foroutan M, Bhuva DD, Lyu R, Horan K, Cursons J, Davis MJ (2018) Single sample scoring of molecular phenotypes. BMC Bioinforma 19:404","journal-title":"BMC Bioinforma"},{"key":"496_CR33","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202052252","volume":"22","author":"B Fu","year":"2021","unstructured":"Fu B, Lin X, Tan S, Zhang R, Xue W, Zhang H, Zhang S, Zhao Q, Wang Y, Feldman K et al (2021) MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell death. EMBO Rep 22:e52252","journal-title":"EMBO Rep"},{"key":"496_CR34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nbt.3269","volume":"33","author":"D Gaidatzis","year":"2015","unstructured":"Gaidatzis D, Burger L, Florescu M, Stadler MB (2015) Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation. Nat Biotechnol 33:722\u2013729","journal-title":"Nat Biotechnol"},{"key":"496_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16170-3","volume":"11","author":"JY Ge","year":"2020","unstructured":"Ge JY, Shu S, Kwon M, Jovanovic B, Murphy K, Gulvady A, Fassl A, Trinh A, Kuang Y, Heavey GA et al (2020) Acquired resistance to combined BET and CDK4\/6 inhibition in triple-negative breast cancer. Nat Commun 11:2350","journal-title":"Nat Commun"},{"key":"496_CR36","first-page":"1812","volume":"54","author":"C Gillett","year":"1994","unstructured":"Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812\u20131817","journal-title":"Cancer Res"},{"key":"496_CR37","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1158\/1078-0432.CCR-24-2647","volume":"31","author":"S Goel","year":"2025","unstructured":"Goel S, Jovanovic B, Chu X, Hughes M, Erick TK, Russo D, DiLullo M, Wrabel E, Jeselsohn R, Lin NU et al (2025) A phase II study of abemaciclib for patients with retinoblastoma-positive, metastatic triple-negative breast cancer. Clin Cancer Res 31:1427\u20131436","journal-title":"Clin Cancer Res"},{"key":"496_CR38","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/1541-7786.MCR-17-0606","volume":"16","author":"PS Gowda","year":"2018","unstructured":"Gowda PS, Wildman BJ, Trotter TN, Xu X, Hao X, Hassan MQ, Yang Y (2018) Runx2 suppression by miR-342 and miR-363 inhibits multiple myeloma progression. Mol Cancer Res 16:1138\u20131148","journal-title":"Mol Cancer Res"},{"key":"496_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123:725\u2013731","journal-title":"Breast Cancer Res Treat"},{"key":"496_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3892\/etm.2013.915","volume":"5","author":"YJ He","year":"2013","unstructured":"He YJ, Wu JZ, Ji MH, Ma T, Qiao EQ, Ma R, Tang JH (2013) miR-342 is associated with estrogen receptor-alpha expression and response to tamoxifen in breast cancer. Exp Ther Med 5:813\u2013818","journal-title":"Exp Ther Med"},{"key":"496_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576\u2013589","journal-title":"Mol Cell"},{"key":"496_CR42","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1128\/MCB.00737-14","volume":"34","author":"DP Hollern","year":"2014","unstructured":"Hollern DP, Honeysett J, Cardiff RD, Andrechek ER (2014) The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Mol Cell Biol 34:3229\u20133243","journal-title":"Mol Cell Biol"},{"key":"496_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jim.2006.09.010","volume":"317","author":"K Ikeda","year":"2006","unstructured":"Ikeda K, Satoh M, Pauley KM, Fritzler MJ, Reeves WH, Chan EK (2006) Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods 317:38\u201344","journal-title":"J Immunol Methods"},{"key":"496_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-60327-475-3_6","volume":"488","author":"KB Jensen","year":"2008","unstructured":"Jensen KB, Darnell RB (2008) CLIP: crosslinking and immunoprecipitation of in vivo RNA targets of RNA-binding proteins. Methods Mol Biol 488:85\u201398","journal-title":"Methods Mol Biol"},{"key":"496_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-023-02677-x","volume":"30","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Ouyang Q, Sun T, Zhang Q, Teng Y, Cui J, Wang H, Yin Y, Wang X, Zhou X et al (2024) Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nat Med 30:249\u2013256","journal-title":"Nat Med"},{"key":"496_CR46","doi-asserted-by":"publisher","first-page":"dmm032250","DOI":"10.1242\/dmm.032250","volume":"11","author":"CN Johnstone","year":"2018","unstructured":"Johnstone CN, Pattison AD, Gorringe KL, Harrison PF, Powell DR, Lock P, Baloyan D, Ernst M, Stewart AG, Beilharz TH et al (2018) Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer. Dis Model Mech 11:dmm032250","journal-title":"Dis Model Mech"},{"key":"496_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113564","volume":"42","author":"B Jovanovic","year":"2023","unstructured":"Jovanovic B, Temko D, Stevens LE, Seehawer M, Fassl A, Murphy K, Anand J, Garza K, Gulvady A, Qiu X et al (2023) Heterogeneity and transcriptional drivers of triple-negative breast cancer. Cell Rep 42:113564","journal-title":"Cell Rep"},{"key":"496_CR48","first-page":"2069","volume":"5","author":"FS Kenny","year":"1999","unstructured":"Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL, Robertson JF (1999) Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin Cancer Res 5:2069\u20132076","journal-title":"Clin Cancer Res"},{"key":"496_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14:R36","journal-title":"Genome Biol"},{"key":"496_CR50","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.7150\/thno.19904","volume":"8","author":"X Lai","year":"2018","unstructured":"Lai X, Gupta SK, Schmitz U, Marquardt S, Knoll S, Spitschak A, Wolkenhauer O, Putzer BM, Vera J (2018) MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance. Theranostics 8:1106\u20131120","journal-title":"Theranostics"},{"key":"496_CR51","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig 121:2750\u20132767","journal-title":"J Clin Investig"},{"key":"496_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26502-6","volume":"12","author":"BD Lehmann","year":"2021","unstructured":"Lehmann BD, Colaprico A, Silva TC, Chen J, An H, Ban Y, Huang H, Wang L, James JL, Balko JM et al (2021) Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes. Nat Commun 12:6276","journal-title":"Nat Commun"},{"key":"496_CR53","doi-asserted-by":"crossref","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Genome Project Data Processing S (2009) The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25:2078\u20132079","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"496_CR54","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/onc.2013.370","volume":"33","author":"X Li","year":"2014","unstructured":"Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ et al (2014) MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Oncogene 33:4077\u20134088","journal-title":"Oncogene"},{"key":"496_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13923","volume":"8","author":"T Liu","year":"2017","unstructured":"Liu T, Yu J, Deng M, Yin Y, Zhang H, Luo K, Qin B, Li Y, Wu C, Ren T et al (2017) CDK4\/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nat Commun 8:13923","journal-title":"Nat Commun"},{"key":"496_CR56","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/bcr2257","volume":"11","author":"AJ Lowery","year":"2009","unstructured":"Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G et al (2009) MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer. Breast Cancer Res: BCR 11:R27","journal-title":"Breast Cancer Res: BCR"},{"key":"496_CR57","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41416-023-02523-4","volume":"130","author":"L Lyu","year":"2024","unstructured":"Lyu L, Li H, Lu K, Jiang S, Li H (2024) PAK inhibitor FRAX486 decreases the metastatic potential of triple-negative breast cancer cells by blocking autophagy. Br J Cancer 130:394\u2013405","journal-title":"Br J Cancer"},{"key":"496_CR58","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1073\/pnas.1019736108","volume":"108","author":"KL Meerbrey","year":"2011","unstructured":"Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, Herschkowitz JI, Burrows AE, Ciccia A, Sun T et al (2011) The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 108:3665\u20133670","journal-title":"Proc Natl Acad Sci USA"},{"key":"496_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41571-023-00840-4","volume":"21","author":"L Morrison","year":"2024","unstructured":"Morrison L, Loibl S, Turner NC (2024) The CDK4\/6 inhibitor revolution\u2014a game-changing era for breast cancer treatment. Nat Rev Clin Oncol 21:89\u2013105","journal-title":"Nat Rev Clin Oncol"},{"key":"496_CR60","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s44318-025-00371-x","volume":"44","author":"J Nehme","year":"2025","unstructured":"Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U, Soto-Gamez A, Altulea A, Gheorghe T, Wang B et al (2025) Pharmacological CDK4\/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer. EMBO J 44:1921\u20131942","journal-title":"EMBO J"},{"key":"496_CR61","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/cells9071643","volume":"9","author":"M Oshi","year":"2020","unstructured":"Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Nagahashi M, Matsuyama R, Endo I, Takabe K (2020) The E2F pathway score as a predictive biomarker of response to neoadjuvant therapy in ER+\/HER2- breast cancer. Cells 9:1643","journal-title":"Cells"},{"key":"496_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-020-0160-4","volume":"6","author":"JM Patel","year":"2020","unstructured":"Patel JM, Goss A, Garber JE, Torous V, Richardson ET, Haviland MJ, Hacker MR, Freeman GJ, Nalven T, Alexander B et al (2020) Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ Breast Cancer 6:19","journal-title":"NPJ Breast Cancer"},{"key":"496_CR63","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ncb2769","volume":"15","author":"N Pencheva","year":"2013","unstructured":"Pencheva N, Tavazoie SF (2013) Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 15:546\u2013554","journal-title":"Nat Cell Biol"},{"key":"496_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04844-3","volume":"13","author":"L Peng","year":"2022","unstructured":"Peng L, Zhao M, Liu T, Chen J, Gao P, Chen L, Xing P, Wang Z, Di J, Xu Q et al (2022) A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway. Cell Death Dis 13:395","journal-title":"Cell Death Dis"},{"key":"496_CR65","doi-asserted-by":"publisher","first-page":"e91884","DOI":"10.1371\/journal.pone.0091884","volume":"9","author":"LG Perez-Rivas","year":"2014","unstructured":"Perez-Rivas LG, Jerez JM, Carmona R, de Luque V, Vicioso L, Claros MG, Viguera E, Pajares B, Sanchez A, Ribelles N et al (2014) A microRNA signature associated with early recurrence in breast cancer. PLoS One 9:e91884","journal-title":"PLoS One"},{"key":"496_CR66","doi-asserted-by":"publisher","first-page":"e99016","DOI":"10.15252\/embj.201899016","volume":"37","author":"KA Pillman","year":"2018","unstructured":"Pillman KA, Phillips CA, Roslan S, Toubia J, Dredge BK, Bert AG, Lumb R, Neumann DP, Li X, Conn SJ et al (2018) miR-200\/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. EMBO J 37:e99016","journal-title":"EMBO J"},{"key":"496_CR67","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1093\/nar\/gkz664","volume":"47","author":"KA Pillman","year":"2019","unstructured":"Pillman KA, Scheer KG, Hackett-Jones E, Saunders K, Bert AG, Toubia J, Whitfield HJ, Sapkota S, Sourdin L, Pham H et al (2019) Extensive transcriptional responses are co-ordinated by microRNAs as revealed by exon-intron split analysis (EISA). Nucleic Acids Res 47:8606\u20138619","journal-title":"Nucleic Acids Res"},{"key":"496_CR68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrc3645","volume":"14","author":"M Radu","year":"2014","unstructured":"Radu M, Semenova G, Kosoff R, Chernoff J (2014) PAK signalling during the development and progression of cancer. Nat Rev Cancer 14:13\u201325","journal-title":"Nat Rev Cancer"},{"key":"496_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29708-9","volume":"8","author":"SL Romero-Cordoba","year":"2018","unstructured":"Romero-Cordoba SL, Rodriguez-Cuevas S, Bautista-Pina V, Maffuz-Aziz A, D\u2019Ippolito E, Cosentino G, Baroni S, Iorio MV, Hidalgo-Miranda A (2018) Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer. Sci Rep 8:12252","journal-title":"Sci Rep"},{"key":"496_CR70","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/cancers15082211","volume":"15","author":"L Saleh","year":"2023","unstructured":"Saleh L, Ottewell PD, Brown JE, Wood SL, Brown NJ, Wilson C, Park C, Ali S, Holen I (2023) The CDK4\/6 INHIBITOR PALBOCICLIB INHIBITS ESTROGEN-POSITIVE AND TRIPLE NEGATIVE BREAST CANCER BONE METASTASIS IN Vivo. Cancers 15:2211","journal-title":"Cancers"},{"key":"496_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24273-8","volume":"12","author":"M Samuel","year":"2021","unstructured":"Samuel M, Fonseka P, Sanwlani R, Gangoda L, Chee SH, Keerthikumar S, Spurling A, Chitti SV, Zanker D, Ang CS et al (2021) Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis. Nat Commun 12:3950","journal-title":"Nat Commun"},{"key":"496_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6103-5","volume":"19","author":"TM Shekhar","year":"2019","unstructured":"Shekhar TM, Burvenich IJG, Harris MA, Rigopoulos A, Zanker D, Spurling A, Parker BS, Walkley CR, Scott AM, Hawkins CJ (2019) Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice. BMC Cancer 19:924","journal-title":"BMC Cancer"},{"key":"496_CR73","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.molcel.2020.04.027","volume":"78","author":"S Shu","year":"2020","unstructured":"Shu S, Wu HJ, Ge JY, Zeid R, Harris IS, Jovanovic B, Murphy K, Wang B, Qiu X, Endress JE et al (2020) Synthetic lethal and resistance interactions with BET bromodomain inhibitors in triple-negative breast cancer. Mol Cell 78:1096\u20131113.e1098","journal-title":"Mol Cell"},{"key":"496_CR74","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/msb.2011.23","volume":"7","author":"WL Su","year":"2011","unstructured":"Su WL, Kleinhanz RR, Schadt EE (2011) Characterizing the role of miRNAs within gene regulatory networks using integrative genomics techniques. Mol Syst Biol 7:490","journal-title":"Mol Syst Biol"},{"key":"496_CR75","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"496_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88924-y","volume":"11","author":"MR Swiatnicki","year":"2021","unstructured":"Swiatnicki MR, Andrechek ER (2021) Metastasis is altered through multiple processes regulated by the E2F1 transcription factor. Sci Rep 11:9502","journal-title":"Sci Rep"},{"key":"496_CR77","first-page":"1464","volume":"36","author":"MC Tai","year":"2015","unstructured":"Tai MC, Kajino T, Nakatochi M, Arima C, Shimada Y, Suzuki M, Miyoshi H, Yatabe Y, Yanagisawa K, Takahashi T (2015) miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis 36:1464\u20131473","journal-title":"Carcinogenesis"},{"key":"496_CR78","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1158\/0008-5472.CAN-17-2210","volume":"77","author":"ZL Teo","year":"2017","unstructured":"Teo ZL, Versaci S, Dushyanthen S, Caramia F, Savas P, Mintoff CP, Zethoven M, Virassamy B, Luen SJ, McArthur GA et al (2017) Combined CDK4\/6 and PI3Kalpha inhibition is synergistic and immunogenic in triple-negative breast cancer. Cancer Res 77:6340\u20136352","journal-title":"Cancer Res"},{"key":"496_CR79","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nbt.2450","volume":"31","author":"C Trapnell","year":"2013","unstructured":"Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L (2013) Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31:46\u201353","journal-title":"Nat Biotechnol"},{"key":"496_CR80","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/annonc\/mdp209","volume":"20","author":"D Trere","year":"2009","unstructured":"Trere D, Brighenti E, Donati G, Ceccarelli C, Santini D, Taffurelli M, Montanaro L, Derenzini M (2009) High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. Ann Oncol 20:1818\u20131823","journal-title":"Ann Oncol"},{"key":"496_CR81","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/sj.bjc.6605787","volume":"103","author":"I Van der Auwera","year":"2010","unstructured":"Van der Auwera I, Limame R, van Dam P, Vermeulen PB, Dirix LY, Van Laere SJ (2010) Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer 103:532\u2013541","journal-title":"Br J Cancer"},{"key":"496_CR82","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/carcin\/bgr081","volume":"32","author":"H Wang","year":"2011","unstructured":"Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W (2011) MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 32:1033\u20131042","journal-title":"Carcinogenesis"},{"key":"496_CR83","doi-asserted-by":"publisher","first-page":"16777","DOI":"10.1074\/jbc.M115.710152","volume":"291","author":"C Weng","year":"2016","unstructured":"Weng C, Nguyen T, Shively JE (2016) miRNA-342 regulates CEACAM1-induced lumen formation in a three-dimensional model of mammary gland morphogenesis. J Biol Chem 291:16777\u201316786","journal-title":"J Biol Chem"},{"key":"496_CR84","doi-asserted-by":"publisher","first-page":"e164227","DOI":"10.1172\/JCI164227","volume":"134","author":"J Winkler","year":"2024","unstructured":"Winkler J, Tan W, Diadhiou CM, McGinnis CS, Abbasi A, Hasnain S, Durney S, Atamaniuc E, Superville D, Awni L et al (2024) Single-cell analysis of breast cancer metastasis reveals epithelial-mesenchymal plasticity signatures associated with poor outcomes. J Clin Invest 134:e164227","journal-title":"J Clin Invest"},{"key":"496_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ (2018) SCANPY: large-scale single-cell gene expression data analysis. Genome Biol 19:15","journal-title":"Genome Biol"},{"key":"496_CR86","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1073\/pnas.1722617115","volume":"115","author":"T Xiao","year":"2018","unstructured":"Xiao T, Li W, Wang X, Xu H, Yang J, Wu Q, Huang Y, Geradts J, Jiang P, Fei T et al (2018) Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc Natl Acad Sci USA 115:7869\u20137878","journal-title":"Proc Natl Acad Sci USA"},{"key":"496_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413103","volume":"12","author":"Y Yang","year":"2025","unstructured":"Yang Y, Liao J, Pan Z, Meng J, Zhang L, Shi W, Wang X, Zhang X, Zhou Z, Luo J et al (2025) Dual inhibition of CDK4\/6 and CDK7 suppresses triple-negative breast cancer progression via epigenetic modulation of SREBP1-regulated cholesterol metabolism. Adv Sci 12:e2413103","journal-title":"Adv Sci"},{"key":"496_CR88","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41591-025-03630-w","volume":"31","author":"Y Yin","year":"2025","unstructured":"Yin Y, Fan Y, Ouyang Q, Song L, Wang X, Li W, Li M, Yan X, Wang S, Sun T et al (2025) Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial. Nat Med 31:1969\u20131975","journal-title":"Nat Med"},{"key":"496_CR89","doi-asserted-by":"publisher","first-page":"99978","DOI":"10.18632\/oncotarget.21577","volume":"8","author":"J Young","year":"2017","unstructured":"Young J, Kawaguchi T, Yan L, Qi Q, Liu S, Takabe K (2017) Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival. Oncotarget 8:99978\u201399989","journal-title":"Oncotarget"},{"key":"496_CR90","doi-asserted-by":"publisher","first-page":"727915","DOI":"10.3389\/fendo.2021.727915","volume":"12","author":"D Zhang","year":"2021","unstructured":"Zhang D, Yamaguchi S, Zhang X, Yang B, Kurooka N, Sugawara R, Albuayjan HHH, Nakatsuka A, Eguchi J, Hiyama TY et al (2021) Upregulation of Mir342 in diet-induced obesity mouse and the hypothalamic appetite control. Front Endocrinol 12:727915","journal-title":"Front Endocrinol"},{"key":"496_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137","journal-title":"Genome Biol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00496-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:31:53Z","timestamp":1789021913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00496-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":91,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,10]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00496-4","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}